Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

We aimed to determine whether uncertainties identified by the European Medicines Agency (EMA) were associated with negative relative effectiveness assessments (REAs) and negative overall reimbursement recommendations by national health technology assessment (HTA) agencies. Therefore, we identified a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Transl Sci
Auteurs principaux: Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W. L., Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert G. M., Klungel, Olaf H., Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8301545/
https://ncbi.nlm.nih.gov/pubmed/33786991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.13027
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires